Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Mauro

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Haematologica|February 9, 1999
Functional and clinical relevance of CD44 variant isoform expression on B-cell chronic lymphocytic leukemia cellsD Zarcone, G De Rossi, C Tenca, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Interferon therapy for Ph1-positive chronic myelogenous leukaemia patients relapsing after T-cell depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, M Screnci, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Alpha-2b-interferon as single therapy for patients with chronic myeloid leukemia relapsing after T-cell depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, M Screnci, et al.
British Journal of Haematology|May 31, 2001
Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemiaM R Ricciardi, M T Petrucci, C Gregorj, et al.
Leukemia|January 13, 2019
IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemiaG Reda, R Cassin, M Gentile, et al.
Blood|May 30, 1998
p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosisI Cordone, S Masi, F R Mauro, et al.
British Journal of Haematology|December 3, 1999
VH gene usage by family members affected with chronic lymphocytic leukaemiaO Pritsch, X Troussard, C Magnac, et al.
Haematologica|January 1, 1994
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphomaP L Zinzani, M G Levrero, F Lauria, et al.
Leukemia|October 12, 1999
Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemiaS Bevan, D Catovsky, A Marossy, et al.
Leukemia|February 5, 2015
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive diseaseF R Mauro, S Chauvie, F Paoloni, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Haematologica|February 9, 1999
Functional and clinical relevance of CD44 variant isoform expression on B-cell chronic lymphocytic leukemia cellsD Zarcone, G De Rossi, C Tenca, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Interferon therapy for Ph1-positive chronic myelogenous leukaemia patients relapsing after T-cell depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, M Screnci, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Alpha-2b-interferon as single therapy for patients with chronic myeloid leukemia relapsing after T-cell depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, M Screnci, et al.
British Journal of Haematology|May 31, 2001
Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemiaM R Ricciardi, M T Petrucci, C Gregorj, et al.
Leukemia|January 13, 2019
IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemiaG Reda, R Cassin, M Gentile, et al.
Blood|May 30, 1998
p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosisI Cordone, S Masi, F R Mauro, et al.
British Journal of Haematology|December 3, 1999
VH gene usage by family members affected with chronic lymphocytic leukaemiaO Pritsch, X Troussard, C Magnac, et al.
Haematologica|January 1, 1994
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphomaP L Zinzani, M G Levrero, F Lauria, et al.
Leukemia|October 12, 1999
Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemiaS Bevan, D Catovsky, A Marossy, et al.
Leukemia|February 5, 2015
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive diseaseF R Mauro, S Chauvie, F Paoloni, et al.
Pageof 5